Polar Capital Holdings’s Pliant Therapeutics PLRX Stock Holding History

Polar Capital Holdings’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,015,000	Closed	-$26.5M	–	310
2024 Q4	$26.5M	Hold	2,015,000	–	–	0.15%	135
2024 Q3	$22.6M	Hold	2,015,000	–	–	0.11%	135
2024 Q2	$21.7M	Hold	2,015,000	–	–	0.13%	126
2024 Q1	$30M	Hold	2,015,000	–	–	0.16%	117
2023 Q4	$36.5M	Buy	2,015,000 +350,000	+21%	+$5.32M	0.22%	97
2023 Q3	$28.9M	Buy	1,665,000 +25,000	+2%	+$433K	0.21%	114
2023 Q2	$29.7M	Sell	1,640,000 -143,164	-8%	-$3.39M	0.15%	123
2023 Q1	$47.4M	Buy	1,783,164 +150,000	+9%	+$4.27M	0.31%	88
2022 Q4	$31.6M	Buy	1,633,164 +533,164	+48%	+$11.1M	0.25%	110
2022 Q3	$23K	Buy	+1,100,000	New	+$21M	0.15%	133

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Polar Capital Holdings's PLRX Position: Q1 2025 in Review

Polar Capital Holdings sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 2,015,000 shares — an estimated $26.5M sold.

Polar Capital Holdings first reported a position in PLRX in Q3 2022 and held it in 10 quarters. The position peaked at $47.4M in Q1 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

Polar Capital Holdings reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
Polar Capital Holdings sold 2,015,000 Pliant Therapeutics shares in Q1 2025, an estimated $26.5M.
Polar Capital Holdings first reported a position in Pliant Therapeutics in Q3 2022 and held it in 10 quarters.
Polar Capital Holdings's Pliant Therapeutics position peaked at $47.4M in Q1 2023.
140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Polar Capital Holdings's 13F filing for Q1 2025, filed 15 May 2025.